Having already established that SPRTN-KO cells are sensitive to DPC-inducing drugs and that SPRTN has proteolytic activity both in vivo and in vitro, we asked if cells derived from patients with Ruijs-Aalfs syndrome were also compromised in DPC resolving activity. Here, SPRTN is linked to progeroid features-hepatocellular carcinoma predisposition syndrome.